Influenza Vaccination and the Vaccination Ecosystem
An excerpt from the Sabin Aspen Vaccine Science & Policy Group report, “Accelerating the Development of a Universal Influenza Vaccine”.
In this white paper from the report, “Accelerating the Development of a Universal Influenza Vaccine”, author Michael Watson identifies key elements of a vaccination ecosystem, details lessons learned from SARS, H1N1 (2009) and H5N1 surveillance, and offers options for improving and harmonizing global influenza vaccination.
“A functioning, healthy, and sustainable ecosystem would make research, development, and production of vaccines a priority, technically possible, affordable, and rewarding for both producers and purchasers.”
Michael Watson, M.B.Ch.B., M.R.C.P., A.F.P.M., is senior vice president of Vaccine Partnerships and Health Impact at Moderna Therapeutics in Cambridge, Massachusetts, and a U.K.-trained physician in internal medicine, infectious diseases, and pharmaceutical medicine. Watson has also worked with WHO, Gavi, the Bill & Melinda Gates Foundation, and other partners on polio eradication, pandemic influenza, HIV and cholera vaccines, and the recently launched dengue vaccine.